| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.0M | +102.8% |
| Cost of Revenue | $21.3M | +124.6% |
| Gross Profit | $10.7M | +69.8% |
| R&D Expense | $942K | +346.0% |
| SG&A Expense | $2.8M | +59.9% |
| Operating Income | -$6.0M | -269.3% |
| Net Income | -$5.8M | -473.0% |
| EPS (Basic) | -$0.76 | -300.0% |
| EPS (Diluted) | -$0.76 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.5M | +236.9% |
| Short-term Investments | $1.5M | -50.6% |
| Accounts Receivable | $14K | +175.8% |
| Inventory | $4.0M | +122.7% |
| Current Assets | $29.9M | +128.6% |
| Total Assets | $38.2M | +85.6% |
| Current Liabilities | $3.8M | +75.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | -112.9% |
| Capital Expenditures | $3.4M | +73.4% |
| Investing Cash Flow | -$196K | +97.6% |
| Financing Cash Flow | $20.9M | +29.9% |
| Free Cash Flow | -$7.5M | -93.2% |
| -300.0% |
| Long-term Debt |
| $500K |
| +0.0% |
| Total Liabilities | $5.2M | +33.6% |
| Stockholders' Equity | $28.4M | +70.3% |